Background The management of patients with carcinoid heart disease poses two major
challenges for the anaesthetist: carcinoid crisis and low cardiac output secondary to right …

Abstract Purpose of Review Carcinoid heart disease is a rare disorder that is associated with
significant morbidity and mortality. In this review of the literature, we will present current …

THE LAST DECADE has witnessed significant breakthroughs in diagnosis and management
of neuroendocrine carcinoid tumors. This field is currently one of the most dynamic areas of …

This review covers the incidence, prognosis, diagnosis and treatment of midgut carcinoids
with emphasis on the surgical and peri-operative aspects. Midgut carcinoids are rare neuro …

To correlate clinical and laboratory variables in carcinoid heart disease, clinical data,
echocardiograms, 24-hour urinary 5-hydroxyindoleacetic acid levels and liver function tests …

Carcinoid heart disease (CaHD) is an important complication among patients with metastatic
neuroendocrine tumors and carcinoid syndrome (CS). CS patients (25%-65%) eventually …

BACKGROUND AND OBJECTIVE: Carcinoid syndrome may involve right carcinoid heart
disease (CHD), secondary to the release of vasoactive substances. Left CHD is rare, as the …

Progress in the medical and surgical management of patients with carcinoid disease has
resulted in improved symptoms and survival. Carcinoid heart disease remains a major …

Background Carcinoid heart disease is a rare disease which develops in patients with
functional neuroendocrine tumors in an advanced tumor state. Patients diagnosed with …

Opinion statement Carcinoid is a rare neuroendocrine tumor that typically originates in the
gastrointestinal tract and can result in a constellation of symptoms, mediated by vasoactive …